Slum dwellers to get free testing, treatment for hepatitis C, TB

Islamabad : Slum dwellers of Islamabad will now get screening, testing and treatment for hepatitis C and other infectious diseases like tuberculosis (TB).

Federal Minister of National Health Services Aamer Mehmood Kiani made this announcement while inaugurating a free Model Centre for Infectious Diseases at the G-7/3 dispensary.

“The government is revamping all health services in Islamabad to convert it into a Model City. In this project, we will start from screening underserved communities of ICT. Teams will go door-to-door in slum communities to screen high-risk individuals. Those found positive will be referred to this Center for confirmation of the disease and its treatment,” Kiani stated.

Hepatitis C patients will be cured with three months’ oral tablets treatment with no side effects. Hepatitis B vaccine will also be given to patients undergoing hepatitis C treatment.

All testing, treatment and hepatitis B vaccination will be done free of cost. Dedicated staff will ensure the follow-up of patients in the community to maximize treatment compliance and response.

While speaking to the media, Kiani further elaborated the operations of the Centre.

He said, “We will carry out a vigorous campaign in these communities using innovative modes of communications to raise awareness for health-seeking behaviours, precautionary measurements and information about the Centre. The purpose is to sensitize masses in an effective manner rather than using conventional modes of communication.”

Pakistan has the second highest disease burden of Hepatitis C in the world, with almost 10 million people affected. Inadequately screened blood transfusions; inappropriately sterilized medical/surgical/dental/gynecological instruments; and sharing of razors, shaving blades and toothbrushes are the most significant risk factors for transmission of the Hepatitis C in Pakistan.

If left untreated, many people will develop life-threatening complications including liver cancer.